Solute Carrier Family 18 (Vesicular Monoamine Transporter), Member 1 (SLC18A1) (Middle Region) Peptid
SLC18A1
Reaktivität: Human
Wirt: Synthetic
BP, WB, IHC
Produktnummer ABIN983840
150,78 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach:
Deutschland
Lieferung in 15 bis 22 Werktagen
Kurzübersicht für Solute Carrier Family 18 (Vesicular Monoamine Transporter), Member 1 (SLC18A1) (Middle Region) Peptid (ABIN983840)
Target
SLC18A1
(Solute Carrier Family 18 (Vesicular Monoamine Transporter), Member 1 (SLC18A1))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Protein Region
- Middle Region
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-SLC18A1 antibody (Catalog #: ARP35649_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Aufreinigung
- Purified
-
-
Solute Carrier Family 18 (Vesicular Monoamine Transporter), Member 1 (SLC18A1) peptide
SLC18A1 Wirt: Synthetic BP, WB, IHC
-
-
Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Konzentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- SLC18A1 (Solute Carrier Family 18 (Vesicular Monoamine Transporter), Member 1 (SLC18A1))
-
Hintergrund
-
The vesicular monoamine transporter acts to accumulate cytosolic monoamines into vesicles, using the proton gradient maintained across the vesicular membrane. Its proper function is essential to the correct activity of the monoaminergic systems that have been implicated in several human neuropsychiatric disorders. The transporter is a site of action of important drugs, including reserpine and tetrabenazineThe vesicular monoamine transporter acts to accumulate cytosolic monoamines into vesicles, using the proton gradient maintained across the vesicular membrane. Its proper function is essential to the correct activity of the monoaminergic systems that have been implicated in several human neuropsychiatric disorders. The transporter is a site of action of important drugs, including reserpine and tetrabenazine (Peter et al., 1993 [PubMed 7905859]). See also SLC18A2 (MIM 193001).[supplied by OMIM]. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
Alias Symbols: CGAT, VAT1, VMAT1
Protein Size: 525 -
Molekulargewicht
- 56 kDa
-
Gen-ID
- 6570
-
NCBI Accession
- NM_003053, NP_003044
-
UniProt
- P54219
Target
-
Sie sind hier:
